Just as Andrew Witty of UnitedHealth Group did in a call with investors last month, CVS Health’s CEO David Joyner defended ...

The second part of our conversation with Craig Burton, MBA, executive director of the Biosimilars Council, a trade and ...

Q4 2024 Earnings Call Transcript February 12, 2025 CVS Health Corporation beats earnings expectations. Reported EPS is $1.19, ...

Operator Good morning, and thank you all for attending the CVS Health Q4 2024 earnings conference call. My name is Brika, and I will be your moderator for today's call. [Operator instructions] I would ...

Rova-T had a convincing-looking mechanism of action ... were in the region of $5 billion per year at peak. It wasn’t a Humira, but AbbVie was realistic enough to accept that it was unlikely ...

The $45-per-share agreement gives AbbVie a pipeline of CNS drugs headed by emraclidine (formerly CVL-231), a drug for schizophrenia with a new mechanism of action that could offer reduced side ...

In addition, many third-generation antibodies designed to trigger different mechanisms of action simultaneously (such as targeting growth factors, inhibiting angiogenesis and restoring apoptosis ...

The Clean Development Mechanism (CDM), defined in Article 12 of the Protocol, allows a country with an emission-reduction or emission-limitation commitment under the Kyoto Protocol (Annex B Party) to ...